2016 Q1 Form 10-K Financial Statement
#000114420416091380 Filed on March 30, 2016
Income Statement
| Concept | 2016 Q1 | 2015 | 2014 Q4 |
|---|---|---|---|
| Revenue | $0.00 | $1.758K | $0.00 |
| YoY Change | -95.62% | -100.0% | |
| Cost Of Revenue | $0.00 | $132.4K | $0.00 |
| YoY Change | -100.0% | ||
| Gross Profit | $0.00 | -$130.7K | $0.00 |
| YoY Change | -425.51% | -100.0% | |
| Gross Profit Margin | -7431.91% | ||
| Selling, General & Admin | $2.178M | $10.27M | $1.720M |
| YoY Change | -19.55% | 17.38% | -23.56% |
| % of Gross Profit | |||
| Research & Development | $150.0K | $2.360M | -$750.0K |
| YoY Change | -73.49% | 112.51% | -302.7% |
| % of Gross Profit | |||
| Depreciation & Amortization | $75.73K | $272.6K | $180.0K |
| YoY Change | 17.87% | -43.24% | 50.0% |
| % of Gross Profit | |||
| Operating Expenses | $2.328M | $12.63M | $980.0K |
| YoY Change | -28.88% | 3.41% | -62.74% |
| Operating Profit | -$2.328M | -$12.76M | -$980.0K |
| YoY Change | -28.88% | 4.83% | -62.45% |
| Interest Expense | $0.00 | $0.00 | |
| YoY Change | -100.0% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | $0.00 | $431.00 | |
| YoY Change | -100.0% | 65.77% | |
| Pretax Income | -$2.328M | -$12.76M | -$3.330M |
| YoY Change | -28.91% | 4.83% | 20.65% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$2.328M | -$15.76M | -$5.810M |
| YoY Change | -30.21% | 7.52% | 110.51% |
| Net Earnings / Revenue | -896491.64% | ||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$11.65M | -$98.50M | -$41.50M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 38.82M shares | 24.56M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2016 Q1 | 2015 | 2014 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.900M | $3.720M | $8.500M |
| YoY Change | -70.1% | -56.24% | 34.92% |
| Cash & Equivalents | $2.883M | $3.720M | $8.501M |
| Short-Term Investments | |||
| Other Short-Term Assets | $0.00 | $580.0K | $0.00 |
| YoY Change | -100.0% | -30.12% | -100.0% |
| Inventory | $0.00 | $9.276K | |
| Prepaid Expenses | $227.9K | $194.0K | |
| Receivables | $298.0K | ||
| Other Receivables | |||
| Total Short-Term Assets | $3.386M | $4.290M | $9.086M |
| YoY Change | -70.22% | -54.07% | 34.37% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $146.0K | $170.0K | $136.7K |
| YoY Change | -61.75% | 21.43% | -16.21% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $76.34K | $80.00K | $48.19K |
| YoY Change | -56.76% | -80.0% | 32.23% |
| Total Long-Term Assets | $1.714M | $1.950M | $2.678M |
| YoY Change | -29.62% | -19.42% | -48.96% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.386M | $4.290M | $9.086M |
| Total Long-Term Assets | $1.714M | $1.950M | $2.678M |
| Total Assets | $5.100M | $6.240M | $11.76M |
| YoY Change | -63.05% | -46.94% | -2.04% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $429.1K | $810.0K | $513.0K |
| YoY Change | -55.59% | 58.82% | 106.75% |
| Accrued Expenses | $169.0K | $1.620M | $254.1K |
| YoY Change | -84.88% | 33.88% | -13.95% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.327M | $2.500M | $2.214M |
| YoY Change | -61.94% | 10.62% | 57.98% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $0.00 | $0.00 | |
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.327M | $2.500M | $2.214M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $1.300M | $2.500M | $2.266M |
| YoY Change | -63.06% | 10.13% | 61.0% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$53.26M | -$35.17M | |
| YoY Change | 38.31% | 71.44% | |
| Common Stock | $38.82K | $24.56K | |
| YoY Change | 42.64% | 32.25% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $3.773M | $3.740M | $9.498M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $5.100M | $6.240M | $11.76M |
| YoY Change | -63.05% | -46.94% | -2.04% |
Cashflow Statement
| Concept | 2016 Q1 | 2015 | 2014 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$2.328M | -$15.76M | -$5.810M |
| YoY Change | -30.21% | 7.52% | 110.51% |
| Depreciation, Depletion And Amortization | $75.73K | $272.6K | $180.0K |
| YoY Change | 17.87% | -43.24% | 50.0% |
| Cash From Operating Activities | -$2.995M | -$13.95M | -$2.720M |
| YoY Change | -0.13% | 32.19% | 2.64% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$10.00K | -$130.0K | -$50.00K |
| YoY Change | -85.71% | -61.76% | -44.44% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | -$160.0K | |
| YoY Change | |||
| Cash From Investing Activities | -$5.020K | -$288.4K | -$50.00K |
| YoY Change | -92.4% | -15.98% | -44.44% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $2.167M | $9.457M | |
| YoY Change | -49.53% | -28.12% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 2.170M | 9.460M | -100.0K |
| YoY Change | -49.42% | -27.57% | -107.19% |
| NET CHANGE | |||
| Cash From Operating Activities | -$2.995M | -$13.95M | -2.720M |
| Cash From Investing Activities | -$5.020K | -$288.4K | -50.00K |
| Cash From Financing Activities | 2.170M | 9.460M | -100.0K |
| Net Change In Cash | -$3.000M | -$14.24M | -2.870M |
| YoY Change | -2.12% | 30.67% | 112.59% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$2.995M | -$13.95M | -$2.720M |
| Capital Expenditures | -$10.00K | -$130.0K | -$50.00K |
| Free Cash Flow | -$2.985M | -$13.82M | -$2.670M |
| YoY Change | 1.92% | 35.32% | 4.3% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2015 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2015 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2015 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2015 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2015Q2 | dei |
Entity Public Float
EntityPublicFloat
|
27422532 | USD |
| CY2015 | dei |
Trading Symbol
TradingSymbol
|
ATOS | |
| CY2016Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
38823464 | shares |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1700565 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
136693 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
11764002 | USD |
| CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
814448 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
513045 | USD |
| CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
463676 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
254126 | USD |
| CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1159335 | USD |
| CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4294851 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
9276 | USD |
| CY2014Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
193964 | USD |
| CY2015Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
193293 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9498127 | USD |
| CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6243321 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8500718 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3715895 | USD |
| CY2015Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
351961 | USD |
| CY2015Q4 | us-gaap |
Assets
Assets
|
6243321 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1886958 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3741734 | USD |
| CY2015 | us-gaap |
Selling Expense
SellingExpense
|
1421409 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12170768 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
44648103 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-35174540 | USD |
| CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
76337 | USD |
| CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
48193 | USD |
| CY2015Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
2483 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
275000 | USD |
| CY2014 | atos |
Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
|
-211493 | USD |
| CY2014Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
0 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
40138 | USD |
| CY2015 | atos |
Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
|
0 | USD |
| CY2015 | us-gaap |
Gross Profit
GrossProfit
|
-130653 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6342161 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12758187 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14657926 | USD |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15760323 | USD |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.61 | |
| CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.55 | |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
24038578 | shares |
| CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
28427523 | shares |
| CY2014 | us-gaap |
Selling Expense
SellingExpense
|
695930 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1110329 | USD |
| CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2359593 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8052281 | USD |
| CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8846963 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
12211166 | USD |
| CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
12627965 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12171028 | USD |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12758618 | USD |
| CY2015 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
431 | USD |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
260 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
301403 | USD |
| CY2014 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
379096 | USD |
| CY2015 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
199594 | USD |
| CY2014 | atos |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-45674 | USD |
| CY2015 | atos |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-2483 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
41916 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
209550 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-91161 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
21900 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10555450 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13953296 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1943540 | USD |
| CY2014 | us-gaap |
Profit Loss
ProfitLoss
|
-14657926 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
15769 | USD |
| CY2015 | us-gaap |
Interest Paid
InterestPaid
|
317 | USD |
| CY2015 | us-gaap |
Profit Loss
ProfitLoss
|
-15760323 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
556288 | USD |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
840103 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
480314 | USD |
| CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
272627 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1450 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
9276 | USD |
| CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-9276 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-1662 | USD |
| CY2015 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-671 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
264903 | USD |
| CY2014 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | USD |
| CY2015 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
355711 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
110663 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9456892 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
13155745 | USD |
| CY2015 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD |
| CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
98481 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9456892 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
13057264 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-288419 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-343257 | USD |
| CY2015 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
275000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2014Q4 | atos |
Working Capital
WorkingCapital
|
1900000 | USD |
| CY2015Q4 | us-gaap |
Prepaid Advertising
PrepaidAdvertising
|
0 | USD |
| CY2014Q4 | us-gaap |
Prepaid Advertising
PrepaidAdvertising
|
50000 | USD |
| CY2015Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
104954 | USD |
| CY2014Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
87633 | USD |
| CY2015Q4 | us-gaap |
Deposit Assets
DepositAssets
|
39218 | USD |
| CY2014Q4 | us-gaap |
Deposit Assets
DepositAssets
|
25000 | USD |
| CY2015Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
49121 | USD |
| CY2014Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
31331 | USD |
| CY2015Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
206337 | USD |
| CY2014Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
363053 | USD |
| CY2015Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
79518 | USD |
| CY2014Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
93664 | USD |
| CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
114287 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
320024 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
285855 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
456717 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
1630000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
1630000 | USD |
| CY2015Q4 | us-gaap |
Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
|
200000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
|
200000 | USD |
| CY2015Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
113540 | USD |
| CY2014Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
112688 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
242975 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
55730 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1942688 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
216110 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
195224 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
169623 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
169015 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
169015 | USD |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
781578 | USD |
| CY2015Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
555345 | USD |
| CY2014Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
655864 | USD |
| CY2015Q4 | atos |
Total Shares Authorized
TotalSharesAuthorized
|
85000000 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
15.00 | |
| CY2014Q2 | atos |
Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
|
0.020 | pure |
| CY2014Q2 | atos |
Entitled To Receive Worth Of Common Stock
EntitledToReceiveWorthOfCommonStock
|
30.00 | |
| CY2015Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2015Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
3465895 | USD |
| CY2014Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
8250718 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
3999674 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.86 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
0 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.43 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.78 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.4 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.14 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
2.45 | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y4M24D | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1557512 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3613944 | shares |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y9M18D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y4M2D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
344000 | USD |
| CY2015 | atos |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue
|
63223 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1726781 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3391660 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3675634 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1845822 | shares |
| CY2015 | atos |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
350000 | shares |
| CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
1907163 | shares |
| CY2015Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1593528 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P2Y7M13D | |
| CY2015 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>NOTE 1: NATURE OF OPERATIONS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in"> Atossa Genetics Inc. (the “Company”) was incorporated on April 30, 2009 in the State of Delaware. The Company was formed to develop and market medical devices, laboratory tests and therapeutics to address breast health conditions. The Company’s fiscal year ends on December 31. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in"> In December 2011, the Company established the National Reference Laboratory for Breast Health, Inc., or NRLBH, as a wholly-owned subsidiary. NRLBH was the Company’s CLIA-certified laboratory which performed the Company’s nipple aspirate fluid, or NAF, cytology test on NAF specimens including those collected with the Company’s <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Mammary Aspiration Specimen Cytology Test (</font>MASCT) System. The current version of the MASCT System is called the ForeCYTE Breast Aspirator. The NRLBH provides other test services, including the pharmacogenomics test. On December 16, 2015 we announced the sale of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 81</font>% of the capital stock of the NRLBH to the NRL Investment Group, LLC, with the Company retaining a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 19</font>% ownership through preferred stock. The Company received $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> at the time of the sale and the right to receive, commencing December 2016, monthly earn-out payments equal to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6</font>% of gross revenue of NRLBH up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,000,000</font>, and the right to sell its preferred stock after four years for the greater of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,000,000</font> or fair market value. The Company has elected to recognize any subsequent gain from the earn-out payments as they are determined realizable. The Earn-out Payments are payable to us each calendar month commencing with December 2016 and is <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6</font>% of NRL gross sales calculated in accordance with U.S. Generally Accepted Accounting Principles.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in"> As a result of the sale of our laboratory business, we are now focusing our business on our pharmaceutical programs. Our key objective is to advance our pharmaceutical candidates through Phase 2 trials and then evaluate further development through partners or independently. A Phase 2 study of fulvestrant administered via our patented intraductal microcatheters was initiated in March 2016 and a Phase 2 study of AfTG is planned to begin enrollment following resolution of our dispute with Besins Healthcare Luxembourg SARL (“Besins”).  </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
110663 | USD |
| CY2014Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
0 | USD |
| CY2015 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1758 | USD |
| CY2014 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
40138 | USD |
| CY2015Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
636239 | USD |
| CY2015 | atos |
Diagnostic Testing Service
DiagnosticTestingService
|
0 | USD |
| CY2014 | atos |
Diagnostic Testing Service
DiagnosticTestingService
|
40138 | USD |
| CY2015 | atos |
Product Sales
ProductSales
|
1758 | USD |
| CY2014 | atos |
Product Sales
ProductSales
|
0 | USD |
| CY2015 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
0 | USD |
| CY2014 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
2352626 | USD |
| CY2015 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | USD |
| CY2014 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
2352626 | USD |
| CY2015 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
-28144 | USD |
| CY2014 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
-11747 | USD |
| CY2015 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
130735 | USD |
| CY2014 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
-158923 | USD |
| CY2015 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
0 | USD |
| CY2014 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
163511 | USD |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-4784823 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2158557 | USD |
| CY2015 | atos |
Non Cash Reclassification Of Furniture And Equipment To Prepaid Expenses
NonCashReclassificationOfFurnitureAndEquipmentToPrepaidExpenses
|
0 | USD |
| CY2014 | atos |
Non Cash Reclassification Of Furniture And Equipment To Prepaid Expenses
NonCashReclassificationOfFurnitureAndEquipmentToPrepaidExpenses
|
15000 | USD |
| CY2015 | atos |
Non Cash Furniture And Fixtures Acquired Through Capital Lease
NonCashFurnitureAndFixturesAcquiredThroughCapitalLease
|
0 | USD |
| CY2014 | atos |
Non Cash Furniture And Fixtures Acquired Through Capital Lease
NonCashFurnitureAndFixturesAcquiredThroughCapitalLease
|
206702 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24564058 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
32657257 | shares |
| CY2015Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
93811 | USD |
| CY2014Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
194224 | USD |
| CY2015Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
510179 | USD |
| CY2014Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
109653 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
194676 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
36100 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
17947 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
9000 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5788496 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4938600 | USD |
| CY2015 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2015 | atos |
Expected Federal Tax Expense Benefit
ExpectedFederalTaxExpenseBenefit
|
6015321 | USD |
| CY2014 | atos |
Expected Federal Tax Expense Benefit
ExpectedFederalTaxExpenseBenefit
|
4983700 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | USD |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32657257 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24564058 | shares |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-4588 | USD |
| CY2015Q4 | atos |
Sale Of Stock Percentage
SaleOfStockPercentage
|
0.81 | pure |
| CY2015Q4 | us-gaap |
Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
|
0.19 | pure |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11397400 | USD |
| CY2015 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
The Company files income tax returns in the U.S. The Company is subject to tax examinations for the 2011 tax year and beyond. | |
| CY2015 | atos |
Operating Loss Carryforwards Description
OperatingLossCarryforwardsDescription
|
2029 through 2035 | |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
46590946 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
17481629 | USD |
| CY2015 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
840103 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
556288 | USD |
| CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9647370 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9709060 | shares |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
0 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
0 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
0 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
250000 | USD |
| CY2015Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
6033426 | shares |
| CY2015 | atos |
Other Research And Development And General And Administration Expenses
OtherResearchAndDevelopmentAndGeneralAndAdministrationExpenses
|
234322 | USD |
| CY2015Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
494252 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-12758187 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-12170768 | USD |
| CY2015 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-3002136 | USD |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-2487158 | USD |
| CY2015 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
-670943 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10601651 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
200000 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
698657 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
894656 | USD |
| CY2015 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-2633943 | USD |
| CY2014 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-2093586 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11319353 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-8461864 | USD |
| CY2015 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
-157684 | USD |
| CY2014 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
-338669 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-130735 | USD |
| CY2015Q4 | atos |
Right To Sell Preferred Stock After Fours Years
RightToSellPreferredStockAfterFoursYears
|
4000000 | USD |
| CY2015 | atos |
Estimated Annualized Forfieture Rate
EstimatedAnnualizedForfietureRate
|
0.10 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
|
5.00 | |
| CY2015 | atos |
Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2015 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
670943 | USD |
| CY2015Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
6033426 | shares |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
250000 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
0 | USD |
| CY2014 | atos |
Other Research And Development And General And Administration Expenses
OtherResearchAndDevelopmentAndGeneralAndAdministrationExpenses
|
149174 | USD |
| CY2015 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
132411 | USD |
| CY2014 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
0 | USD |
| CY2015 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
132411 | USD |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2015Q4 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
50000 | USD |
| CY2015Q4 | atos |
Monthly Earnout Payments Percentage Of Gross Revenue
MonthlyEarnoutPaymentsPercentageOfGrossRevenue
|
0.06 | pure |
| CY2015Q4 | atos |
Maximum Gross Revenue For Monthly Earnout Payments
MaximumGrossRevenueForMonthlyEarnoutPayments
|
10000000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.45 | |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.51 | |
| CY2015 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
-0.10 | |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
-0.10 | |
| CY2014 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
0 | USD |
| CY2015 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
14202 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
33137 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
3200 | USD |
| CY2015 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Use of Estimates:</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">  </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
191900 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
|
165642 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
|
228100 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
35426 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
48400 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
|
31896 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
|
30400 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
900 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
|
232964 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
|
499700 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
15840922 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9772300 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
768232 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
841800 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
851521 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
732400 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
53819 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
53800 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
272 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
300 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
|
17481629 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
|
11397400 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
33137 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
3200 | USD |
| CY2014 | atos |
Stock Issued During Period Common Shares And Warrants
StockIssuedDuringPeriodCommonSharesAndWarrants
|
12655745 | USD |
| CY2015 | atos |
Stock Issued During Period Common Shares And Warrants
StockIssuedDuringPeriodCommonSharesAndWarrants
|
9109274 | USD |
| CY2014 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1378417 | USD |
| CY2015 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1011574 | USD |
| CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
840103 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
556288 | USD |
